Our data suggest that activation of TLR4 by FBG-W within the tumor stroma could directly affect tumor cell phenotype, and/or the behavior of immune cells resident in the tumor microenvironment, to favor pro-tumoral inflammatory signaling, providing a possible molecular explanation for the association between tenascin-W and poor patient survival. The gene discussed is TNN; the disease is neoplasm.